Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunfu Cui

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Bioengineered|February 25, 2022
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2Chao Ding, Tiefeng Shi, Gang Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2018
Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transitionYi Xu, Yue Yao, Wei Qin, et al.
Journal of Clinical and Translational Hepatology|November 21, 2022
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular CarcinomaZiyue Huang, Haoming Xia, Yunfu Cui, et al.
Frontiers in Immunology|August 2, 2023
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapyXinlei Zou, Canghai Guan, Jianjun Gao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 12, 2018
MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinomaChao Ding, Huiming Yu, Chenlei Shi, et al.
Disease Markers|March 14, 2019
Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of CholangiocarcinomaTianyi Fang, Hao Wang, Yufu Wang, et al.
Oncotarget|April 19, 2015
miR-211 suppresses hepatocellular carcinoma by downregulating SATB2Guixing Jiang, Yunfu Cui, Xin Yu, et al.
Pathology, Research and Practice|August 16, 2018
Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancersLining Huang, Xingming Jiang, Zhidong Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Reprogramming of central carbon metabolism in hepatocellular carcinomaHaoming Xia, Ziyue Huang, Yi Xu, et al.
Journal of Clinical and Translational Hepatology|December 31, 2025
Centromere Protein I, a Cell Cycle Checkpoint Gene, Accelerates Tumor Progression via the Hippo Pathway and Mediates Immune Escape in Hepatocellular CarcinomaRisheng He, Yi Xu, Pengbo Zhang, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Bioengineered|February 25, 2022
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2Chao Ding, Tiefeng Shi, Gang Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2018
Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transitionYi Xu, Yue Yao, Wei Qin, et al.
Journal of Clinical and Translational Hepatology|November 21, 2022
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular CarcinomaZiyue Huang, Haoming Xia, Yunfu Cui, et al.
Frontiers in Immunology|August 2, 2023
Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapyXinlei Zou, Canghai Guan, Jianjun Gao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 12, 2018
MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinomaChao Ding, Huiming Yu, Chenlei Shi, et al.
Disease Markers|March 14, 2019
Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of CholangiocarcinomaTianyi Fang, Hao Wang, Yufu Wang, et al.
Oncotarget|April 19, 2015
miR-211 suppresses hepatocellular carcinoma by downregulating SATB2Guixing Jiang, Yunfu Cui, Xin Yu, et al.
Pathology, Research and Practice|August 16, 2018
Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancersLining Huang, Xingming Jiang, Zhidong Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Reprogramming of central carbon metabolism in hepatocellular carcinomaHaoming Xia, Ziyue Huang, Yi Xu, et al.
Journal of Clinical and Translational Hepatology|December 31, 2025
Centromere Protein I, a Cell Cycle Checkpoint Gene, Accelerates Tumor Progression via the Hippo Pathway and Mediates Immune Escape in Hepatocellular CarcinomaRisheng He, Yi Xu, Pengbo Zhang, et al.
Pageof 10